Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

Clinical Trial Description

Prospective, cluster-randomized, open-label, post market, comparative effectiveness evaluation with facilities participating for up to 13 months. ;

Study Design

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05908084` - To Compare the Efficacy and Safety of the HAV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis	Phase 3
Active, not recruiting	`NCT05309109` - Effect of Medium Cut-Off Hemodialysis on Protein Energy Wasting: The EMCOPEW Study	N/A
Not yet recruiting	`NCT04086212` - Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine	Phase 2
Completed	`NCT01783626` - Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)	N/A
Active, not recruiting	`NCT01693263` - Outcome of BCF Access in Hemodialysis Patients
Completed	`NCT01219959` - Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients	Phase 3
Completed	`NCT02278341` - Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis	Phase 3
Withdrawn	`NCT02274896` - Bayston Multicenter Antimicrobial PD Catheter Safety Study	N/A
Completed	`NCT04912050` - EXtension of Tablo TrEatmeNt Duration Registry
Recruiting	`NCT02745340` - Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis	N/A
Completed	`NCT02733328` - Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
Completed	`NCT04292184` - Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation	Phase 1
Completed	`NCT02795286` - Automated Setting of Individualized Sodium Technology	N/A
Active, not recruiting	`NCT02808208` - Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure	Phase 1/Phase 2
Completed	`NCT00559767` - Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium	N/A
Completed	`NCT02433210` - A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients	N/A
Completed	`NCT01594424` - A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation	Phase 1/Phase 2
Completed	`NCT05610683` - Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers	N/A
Completed	`NCT03249532` - Effect of Dialysis Techniques on Blood Pressure and Cardiac Function During Dialysis	N/A
Completed	`NCT02467530` - Food Preparation Effects on Gut Bacteria in Patients on Peritoneal Dialysis	N/A

NCT number	NCT02593149
Study type	Interventional
Source	Pursuit Vascular, Inc.
Contact
Status	Completed
Phase	N/A
Start date	November 2015
Completion date	November 2016

Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms